Relapsed or refractory Hodgkin lymphoma - brentuximab (autologous stem cell transplant (ASCT) naïve) initial PBS authority form (PB205)

This information was printed Monday 20 May 2019 from It may not include all of the relevant information on this topic. Please consider any relevant site notices at when using this material.

Page last updated: 13 February 2019